PFKFB3 overexpression has been associated with a large tumor size and poor survival in patients, while PFKFB3 knockdown inhibits HCC growth by reducing glucose consumption and impeding DNA repair, which leads to cell cycle arrest at the G2/M phase and apoptosis. This evidence concerns the gene PFKFB3 and hepatocellular carcinoma.